Insulin-like growth factor (IGF) system in liver diseases

A Adamek, A Kasprzak - International journal of molecular sciences, 2018 - mdpi.com
Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors
produced in liver. Insulin-like growth factor 1 and 2 (IGF1 and IGF2) act in response to …

Insulin-like growth factor-1 deficiency and metabolic syndrome

GA Aguirre, JR De Ita, RG De La Garza… - Journal of translational …, 2016 - Springer
Consistent evidence associates IGF-1 deficiency and metabolic syndrome. In this review, we
will focus on the metabolic effects of IGF-1, the concept of metabolic syndrome and its …

Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease

C Jouffe, BD Weger, E Martin, F Atger… - Proceedings of the …, 2022 - National Acad Sciences
Obesity and liver diseases are associated with the disruption of the circadian clock that
orchestrates mammalian physiology to optimize nutrient metabolism and storage. Here, we …

Human conditions of insulin-like growth factor-I (IGF-I) deficiency

JE Puche, I Castilla-Cortázar - Journal of translational medicine, 2012 - Springer
Insulin-like growth factor I (IGF-I) is a polypeptide hormone produced mainly by the liver in
response to the endocrine GH stimulus, but it is also secreted by multiple tissues for …

Gonadal dysfunction in systemic diseases

A Karagiannis, F Harsoulis - European Journal of Endocrinology, 2005 - academic.oup.com
Gonadal function is significantly affected in many acute and chronic systemic diseases. As
the function of the testes and the ovaries is determined by the integrity of the hypothalamic …

Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid

S Padmanabhan, DN Tripathi, A Vikram… - … /genetic toxicology and …, 2009 - Elsevier
Methotrexate (MTX) is an anti-metabolite widely used in the treatment of neoplastic
disorders, rheumatoid arthritis and psoriasis. The basis for its therapeutic efficacy is the …

[PDF][PDF] Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver

J Heo, VM Factor, T Uren, Y Takahama, JS Lee… - …, 2006 - Wiley Online Library
We established an efficient system for differentiation, expansion and isolation of hepatic
progenitor cells from mouse embryonic stem (ES) cells and evaluated their capacity to …

Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats

JE Puche, M García-Fernández, J Muntané… - …, 2008 - academic.oup.com
Serum IGF-I levels decline with age. We have recently reported that in aging rats the
exogenous administration of IGF-I restores IGF-I circulating levels and age related-changes …

Is insulin-like growth factor-1 involved in Parkinson's disease development?

I Castilla-Cortázar, GA Aguirre, G Femat-Roldán… - Journal of translational …, 2020 - Springer
Parkinson's disease (PD) is a neurodegenerative disorder that results in the death of
dopaminergic neurons within the substantia nigra pars compacta and the reduction in …

Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial

M Conchillo, RJ de Knegt, M Payeras, J Quiroga… - Journal of …, 2005 - Elsevier
BACKGROUND/AIMS: Insulin-like growth factor I (IGF-I) is an anabolic hormone synthesized
in the liver whose levels decrease sharply in liver cirrhosis. METHODS: We conducted a …